About ThrombusCheck
ThrombusCheck was a Healthcare company based in Palo Alto (United States) founded in 2017. It offers a device that mimics plaqued arteries for personalized anti-platelet therapy. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Medical Devices, Diagnostic Tools and Cardiovascular Therapy. Its competitors include Accumetrics, AggreDYNE, Zabit Pharmaceutical, COC Pharmaceuticals Industry and DCM Pharmaceutical Industry; 2 of its 5 listed competitors have raised funding.
Company details
ThrombusCheck offers a device that mimics plaqued arteries for personalized anti-platelet therapy, focusing on providing healthcare solutions, developing medical devices, diagnostic tools, and cardiovascular therapy. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Palo Alto, United States
- SectorsHealthcare
- Website thrombuscheck.com
Competitors of ThrombusCheck
ThrombusCheck has 5 listed competitors in our database, 2 of them funded. They include Accumetrics, AggreDYNE, Zabit Pharmaceutical, COC Pharmaceuticals Industry and DCM Pharmaceutical Industry, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| accumetrics.com | 1996 | San Diego, United States | $97.53M | 46 | Platelet function assays and coagulation systems are developed and marketed. | |
| aggredyne.com | 2011 | Houston, United States | $3M | – | Platelet stickiness is measured using patented Aggreguide A-100. | |
| zabitpharmaceutical.com | 2011 | London, United Kingdom | – | – | Develops innovative devices for platelet functioning tests. | |
| cocpharmaceuticals.com | 2011 | Glasgow, United Kingdom | – | – | Develops diagnostic devices for platelet function analysis. | |
| dcmpharmaceutical.com | 2011 | London, United Kingdom | – | – | Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare. |
Detailed competitors of ThrombusCheck
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as ThrombusCheck (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ThrombusCheck
ThrombusCheck was founded in 2017.
ThrombusCheck is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
ThrombusCheck offers a device that mimics plaqued arteries for personalized anti-platelet therapy, focusing on providing healthcare solutions, developing medical devices, diagnostic tools, and cardiovascular therapy. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
ThrombusCheck's top competitors include Accumetrics, AggreDYNE and Zabit Pharmaceutical.